Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Vaccines
•
Allergy & Immunology
•
Primary Care
How long do you counsel patients to wait after rituximab therapy before getting live vaccines?
Related Questions
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
Does splitting the dose of a vaccine during an observed administration affect the efficacy of the vaccine response?
Have you been able to safely use other bisphosphonates in patients who developed an allergic reaction (angioedema) to fosamax?
How do you manage recurrent epistaxis from nasal steroids?
Do you feel high dose Symbicort or Dulera is appropriate to use for SMART despite these doses not being studied in clinical trials?
Do you counsel a mother to avoid certain food in her diet if she is still breast feeding and her child has confirmed IgE mediated food allergies?
Which patient characteristics or scenarios drive you to choose tezepelumab over dupilumab for asthma?
When do you consider lifelong AIT?
Do you retest for environmental aeroallergens when patients have relocated within the US between vastly different climates?
When would you favor initiation of mepolizumab versus dupilumab for CRSwNP?
